Phenothiazinyl Merocyanine Dyes
FULL PAPER
m/z (%): 442 (18), 441 (28), 440 (100) [M]+, 369 (23) [MꢀC5H11]+, 355
(30) [MꢀC6H13]+, 254 (42); elemental analysis calcd (%) for
C23H24N2OS3 (440.7): C 62.69, H 5.49, N 6.36; found: C 62.56, H 5.50, N
6.35.
10 f was obtained as a red solid after column chromatography on silica by
using hexane/acetone (15:1) as eluent and after subsequent recrystalliza-
1
tion from dichloromethane and hexane. M.p. 2258C; H NMR (500 MHz,
CD2Cl2): d=0.88 (t, J=6.8 Hz, 3H), 1.28–1.34 (m, 4H), 1.39–1.48 (m,
2H), 1.74–1.83 (m, 2H), 3.49 (s, 3H), 3.86–3.92 (m, 2H), 6.90 (d, J=
8.6 Hz, 1H), 6.96 (d, J=8.6 Hz, 1H), 7.22 (d, J=1.9 Hz, 1H), 7.32–7.37
(m, 2H), 7.45 (dd, J=1.9, 8.5 Hz, 1H), 7.59 ppm (s, 1H); 13C NMR
(125 MHz, CD2Cl2): d=14.1 (CH3), 22.9 (CH2), 26.7 (CH2), 26.8 (CH2),
31.5 (CH3), 31.7 (CH2), 48.5 (CH2), 106.6 (Cquat), 115.0 (CH), 116.6 (CH),
118.7 (Cquat), 121.8 (Cquat), 124.6 (Cquat), 124.9 (Cquat), 129.1 (Cquat), 129.5
(CH), 130.7 (CH), 131.3 (CH), 131.8 (CH), 132.4 (CH), 146.1 (Cquat),
148.1 (Cquat), 168.0 (Cquat), 193.7 ppm (Cquat); IR (KBr): n˜ =2923 (w), 2854
(w), 2221 (m), 1704 (s), 1595 (w), 1575 (m), 1472 (s), 1400 (m), 1290 (s),
1253 (m), 1127 (m), 1108 (m), 915 (w), 801 cmꢀ1 (w); UV/Vis (CH2Cl2):
lmax (e)=294 (25000), 362 (17000), 458 nm (21000 Lmolꢀ1 cmꢀ1); EI-MS:
m/z (%): 467 (16), 466 (30) [M]+, 465 (100) [M]+, 394 (24) [MꢀC5H11]+,
381 (12), 380 (26) [MꢀC6H13]+, 364 (13), 293 (12), 280 (19), 279 (63), 261
(12), 247 (10), 43 (22); elemental analysis calcd (%) for C24H23N3OS3
(465.7): C 61.90, H 4.98, N 9.02; found: C 61.70, H 4.99, N 8.98.
(Z)-5-[(10-Hexyl-7-iodo-10H-phenothiazine-3-yl)methylene]-3-methyl-2-
thioxothiazolidine-4-one (10c): According to GP 1, compound 10c was
obtained as a red solid after column chromatography on silica by using
hexane/acetone (10:1) as eluent. M.p. 1908C; 1H NMR (500 MHz,
CD2Cl2): d=0.82 ꢀ0.94 (m, 3H), 1.24–1.37 (m, 4H), 1.38–1.47 (m, 2H),
1.77 (quint, J=7.5 Hz, 2H), 3.47 (s, 3H), 3.83 (t, J=7.3 Hz, 2H), 6.62 (d,
J=8.6 Hz, 1H), 6.90 (d, J=8.6 Hz, 1H), 7.20 (d, J=2.2 Hz, 1H), 7.31
(dd, J=2.2, 8.6 Hz, 1H), 7.39 (d, J=2.0 Hz, 1H), 7.44 (dd, J=2.0, 8.6 Hz,
1H), 7.58 ppm (s, 1H); 13C NMR (125 MHz, CD2Cl2): d=14.1 (CH3),
22.9 (CH2), 26.8 (CH2), 26.9 (CH2), 31.4 (CH3), 31.7 (CH2), 48.2 (CH2),
116.0 (CH), 117.8 (CH), 120.9 (Cquat), 125.0 (Cquat), 126.2 (Cquat), 128.1
(Cquat), 129.4 (CH), 131.2 (CH), 132.2 (CH), 135.6 (CH), 136.6 (CH),
144.0 (Cquat), 147.4 (Cquat), 168.2 (Cquat), 193.7 ppm (Cquat); IR (KBr): n˜ =
2954 (w), 2926 (w), 1709 (s), 1585 (s), 1560 (w), 1497 (w), 1461 (s), 1292
(s), 1245 (m), 1129 (m), 1108 (m), 988 (w), 931 (w), 797 cmꢀ1 (w);
MALDI MS: m/z (%): 569 (10), 568 (30), 567 (48), 566 (100) [M]+; UV/
Vis (CH2Cl2): lmax (e)=257 (26000), 299 (21000), 362 (20000), 467 nm
(25000 Lmolꢀ1 cmꢀ1); elemental analysis calcd (%) for C23H23IN2OS3
(566.5): C 48.76, H 4.09, N 4.94; found: C 49.00, H 4.26, N 4.86.
2-[(10-Hexyl-7-p-tolyl-10H-phenothiazine-3-yl)methylene]-1H-indene-
1,3(2H)-dione (12a): According to GP 1, compound 12a was obtained as
a red solid after column chromatography on silica by using hexane/ace-
tone (10:1) as eluent; 97.6 mg (0.24 mmol, 40%) starting material was
isolated. M.p. 1558C; 1H NMR (500 MHz, CD2Cl2): d=0.90 (t, J=
6.9 Hz, 3H), 1.28–1.40 (m, 4H), 1.44–1.52 (m, 2H), 1.81–1.90 (m, 2H),
2.37 (s, 3H), 3.93 (t, J=7.4 Hz, 2H), 6.90–6.99 (m, 2H), 7.24 (d, J=
8.1 Hz, 2H), 7.34 (d, J=2.0 Hz, 1H), 7.39 (dd, J=2.0, 8.5 Hz, 1H), 7.45
(d, J=8.1 Hz, 2H), 7.68 (s, 1H), 7.77–7.81 (m, 2H), 7.89–7.99 (m, 2H),
8.29 (dd, J=1.9, 8.7 Hz, 1H), 8.42 ppm (d, J=1.9 Hz, 1H); 13C NMR
(125 MHz, CD2Cl2): d=14.1 (CH3), 21.1 (CH3), 23.0 (CH2), 26.9 (CH2),
27.0 (CH2), 31.8 (CH2), 48.5 (CH2), 114.9 (CH), 116.4 (CH), 123.1 (CH),
123.2 (CH), 123.5 (Cquat), 124.1 (Cquat), 125.7 (CH), 126.1 (CH), 126.5 (2
CH),126.8 (Cquat), 128.1 (Cquat), 129.9 (2 CH), 133.0 (CH), 135.2 (CH),
135.4 (CH), 136.0 (CH), 136.81 (Cquat), 136.83 (Cquat), 137.6 (Cquat), 140.4
(Cquat), 142.2 (Cquat), 142.8 (Cquat), 145.3 (CH), 149.8 (Cquat), 190.0 (Cquat),
190.7 ppm (Cquat); IR (KBr): n˜ =2955 (w), 2927 (w), 2371 (w), 2346 (w),
1683 (m), 1597 (w), 1567 (m), 1469 (s), 1412 (w), 1248 (w), 1204 (m),
1154 (w), 1086 (w), 1051 (w), 998 (w), 802 (w), 735 cmꢀ1 (w); UV/Vis
(CH2Cl2): lmax (e)=268 (50000), 311 (24000), 340 (27000), 519 nm
(29000 Lmolꢀ1 cmꢀ1); EI-MS: m/z (%): 529 (10) [M]+, 444 (13)
[MꢀC6H13]+; elemental analysis calcd (%) for C35H31NO2S (529.7): C
79.36, H 5.90, N 2.64; found C 79.10, H 6.04, N 2.49.
(Z)-5-[(7-Bromo-10-hexyl-10H-phenothiazine-3-yl)methylene]-3-methyl-
2-thioxothiazolidin-4-one (10d): According to GP 2, compound 10d was
obtained as red crystals after purification by column chromatography on
1
silica by using hexane/ethyl acetate (4:1) as eluent. M.p. 1948C; H NMR
(500 MHz, CD2Cl2): d=0.85–0.90 (m, 3H), 1.28–1.33 (m, 4H), 1.39–1.46
(m, 2H), 1.73–1.81 (m, 2H), 3.48 (t, J=7.3 Hz, 2H), 6.75 (d, J=8.7 Hz,
1H), 6.91 (d, J=8.6 Hz, 1H), 7.20–7.24 (m, 2H), 7.27 (dd, J=2.2, 8.6 Hz,
1H), 7.33 (dd, J=2.1, 8.6 Hz, 1H), 7.59 ppm (s, 1H); 13C NMR
(125.5 MHz, CD2Cl2): d=14.1 (CH3), 22.9 (CH2), 26.8 (CH2), 26.9 (CH2),
31.5 (CH3), 31.7 (CH2), 48.3 (CH2), 115.6 (Cquat), 116.0 (CH), 117.4 (CH),
120.9 (Cquat), 124.9 (Cquat), 126.1 (Cquat), 128.1 (Cquat), 129.4 (CH), 129.9
(CH), 130.6 (CH), 131.3 (CH), 132.2 (CH), 143.3 (Cquat), 147.4 (Cquat),
168.0 (Cquat), 193.7 ppm (Cquat); IR (KBr): n˜ =2967 (w), 2927 (w), 2859
(w), 1709 (m), 1586 (s), 1562 (m), 1461 (s), 1405 (m), 1354 (m), 1290 (s),
1246 (m), 1128 (m), 1103 (m), 800 cmꢀ1 (w); UV/Vis (CH2Cl2): lmax (e)=
299 (16000), 361 (16000), 467 nm (21000 Lmolꢀ1 cmꢀ1); EI-MS (70 eV):
81
m/z (%): 522 (14), 521 (26), 520 (100) [Mꢀ Br]+, 519 (24), 518 (86)
79
[Mꢀ Br]+, 449 (22), 447 (19) [MꢀC5H11]+, 435 (40), 433 (38)
[MꢀC6H13]+, 335 (14), 334 (67), 333 (16), 332 (62), 267 (10), 253 (15); el-
emental analysis calcd (%) for C23H23N2OS3Br (519.5): C 53.17, H 4.46,
N 5.39; found: C 53.05, H 4.42, N 5.26.
2-[(10-Hexyl-10H-phenothiazine-3-yl)methylene]-2H-indan-1,3-dione
(12b): According to GP 2, compound 12b was obtained as red crystals
after purification by column chromatography on silica by using hexane/
ethyl acetate (4:1) as eluent. M.p. 1458C; 1H NMR (300 MHz, CD2Cl2):
d=0.84–0.90 (m, 3H), 1.28–1.36 (m, 4H), 1.46–1.56 (m, 2H), 1.80–1.92
(m, 2H), 4.07 (t, J=7.1 Hz, 2H), 7.02 (m, 1H), 7.09–7.27 (m, 4H), 7.68
(s, 1H), 7.89–8.00 (m, 3H), 8.35 (dd, J=8.8, 2.0 Hz, 1H), 8.63 ppm (d,
J=2.1 Hz, 1H); 13C NMR(75 MHz, CD2Cl2): d=14.1 (CH3), 23.0 (CH2),
26.9 (CH2), 27.1 (CH2), 31.8 (CH2), 48.4 (CH2), 115.0 (CH), 116.3 (CH),
123.1 (CH), 123.2 (CH), 123.8 (Cq), 124.0 (CH), 126.9 (Cquat), 127.7 (CH),
127.9 (CH), 128.1 (Cquat), 133.1 (CH), 135.2 (CH), 135.3 (CH), 135.9
(CH), 140.4 (Cquat), 142.8 (Cquat), 143.4 (Cquat), 145.4 (CH), 150.1 (Cquat),
189.7 (Cquat), 190.7 ppm (Cquat); EI-MS (70 eV): m/z (%): 440 (23)
[M+H]+, 439 (84) [M+], 369 (11), 368 (45) [MꢀC5H11]+, 355 (25), 354
(100) [MꢀC6H13]+, 336 (14), 43 (13), 28 (41); IR (KBr): n˜ =3060 (w),
2954 (m), 2926 (m), 2853 (m), 1679 (s), 1609 (m), 1584 (s), 1562 (s), 1496
(m), 1466 (s), 1442 (m), 1414 (s), 1351 (s), 1288 (m), 1251 (m), 1205 (s),
1176 (m), 1156 (m), 1090 (m), 998 (m), 737 cmꢀ1 (s); UV/Vis (CH2Cl2):
lmax (e)=254 (31000), 268 nm (20000 Lmolꢀ1 cmꢀ1); HR-EI: m/z calcd
for C28H25NO2S3: 439.1606, found: 439.1605; elemental analysis calcd (%)
for C28H25NO2S3 (439.6): C 76.51, H 5.73, N 3.19, S 7.29, O 7.28; found: C
76.26, H 6.03, N 3.08, S 7.17, O 7.46.
(Z)-10-Hexyl-7-[(3-methyl-4-oxo-2-thioxothiazolidine-5-ylidene)methyl]-
10H-phenothiazine-3-carbaldehyde (10e): According to GP 2, compound
10e was obtained as a red solid after crystallization and trituration with
methanol. M.p. 1968C; 1H NMR (500 MHz, CD2Cl2): d=0.83–0.93 (m,
3H), 1.27–1.37 (m, 4H), 1.39–1.50 (m, 2H), 1.78–1.85 (m, 2H), 3.48 (s,
3H), 3.91 (t, J =7.4 Hz, 2H), 6.95 (d, J=8.6 Hz, 1H), 6.97 (d, J=8.5 Hz,
1H), 7.21 (d, J=2.1 Hz, 1H), 7.33 (dd, J=2.1 Hz, 3J=8.7 Hz, 1H), 7.56
(d, J=1.9 Hz, 1H) 7.58 (s, 1H), 7.65 (dd, J=1.9, 8.5 Hz, 1H), 9.79 ppm
(s, 1H); 13C NMR (125 MHz, CD2Cl2): d=14.1 (CH3), 22.9 (CH2), 26.7
(CH2), 26.9 (CH2), 31.5 (CH3), 31.7 (CH2), 48.8 (CH2), 115.8 (CH), 116.5
(CH), 121.6 (Cquat), 124.3 (Cquat), 125.0 (Cquat), 128.3 (CH), 128.9 (Cquat),
129.4 (CH), 130.6 (CH), 131.2 (CH), 131.9 (CH), 132.2 (Cquat), 146.0
(Cquat), 149.3 (Cquat), 168.0 (Cquat), 190.0 (CH),193.7 ppm (Cquat); IR
(KBr): n˜ =2929 (w), 2855 (w), 1708 (s), 1687 (s), 1593 (m), 1572 (s), 1544
(w), 1473 (s), 1424 (m), 1402 (s), 1356 (m), 1289 (s), 1251 (s), 1223 (m),
1197 (m), 1128 (s), 1102 (s), 991 (w), 960 (w), 916 (w), 810 (w), 735 cmꢀ1
(w); UV/Vis (CH2Cl2): lmax (e)=300 (83000), 365 (60000), 466 nm
(71000 Lmolꢀ1 cmꢀ1); EI-MS: m/z (%)=470 (11), 469 (17), 468 (52)
[M]+, 397 (17) [MꢀC5H11]+, 383 (27) [MꢀC6H13]+, 296 (11), 284 (11),
283 (23), 282 (110), 264 (17), 254 (13), 43 (14), 28 (42); elemental analysis
calcd (%) for C24H24N2O2S3 (468.7): C 61.51, H 5.16, N 5.98; found: C
61.58, H 5.00, N 6.02.
2-[(10-Hexyl-7-iodo-10H-phenothiazine-3-yl)methylene]-1H-indene-
1,3(2H)-dione (12c): According to GP 1, compound 12c was obtained as
a red solid after column chromatography on silica by using hexane/ace-
(Z)-10-Hexyl-7-[(3-methyl-4-oxo-2-thioxothiazolidine-5-ylidene)methyl]-
10H-phenothiazine-3-carbonitrile (10 f): According to GP 1, compound
1
tone (10:1) as eluent. M.p. 1718C; H NMR (500 MHz, CD2Cl2): d=0.89
Chem. Eur. J. 2011, 17, 9984 – 9998
ꢂ 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
9995